Treatment of recurrence and metastasis of uterine cancer

What should I do if endometrial cancer recurs and metastasizes? When endometrial cancer develops to the late stage, incomplete treatment and unreasonable treatment methods may lead to recurrence and metastasis. So, what should I do if endometrial cancer recurs and metastasizes? Let's take a look at how to introduce it:

What should I do if endometrial cancer recurs and metastasizes?

Late-stage recurrence and metastasis of endometrial cancer include systemic metastasis to the liver, lung, bone, lymph nodes, blood vessels, and recurrence to the pelvic wall and paracervix. Some people have counted the sites of recurrence after radiotherapy.

The clinical symptoms of late-stage recurrence and metastasis of endometrial cancer will also vary depending on the site of recurrence and metastasis. Recurrence in the uterus or vagina often causes irregular vaginal bleeding or foul-smelling leucorrhea; recurrence in the pelvic wall or paracervix may cause pain and edema in the affected lower limb, pain in the lumbosacral region or lower abdomen, and a paracervical mass or a fixed mass in the sacral fossa may be palpated during pelvic examination; metastasis to the rectum or bladder often causes blood in the stool or urine; bone metastasis often causes local pain; lung metastasis may cause coughing and chest pain.

If the above symptoms and signs appear after treatment of endometrial cancer, the possibility of recurrence should be considered. Local recurrence of the cervix and vagina can be diagnosed easily by vaginal smear cytology and biopsy. Attention should be paid to the differentiation of pelvic masses from lymphocele after radical surgery, pelvic wall inflammation, and paracervical connective tissue fibrosis after radiotherapy. Local fine needle puncture for cell smear and pathological examination can help to clarify the diagnosis. B-ultrasound, pyelography, isotope renal imaging and CT pelvic examination have certain reference value for diagnosing recurrent cancer.